MDGL Deferred Revenue
Madrigal Pharmaceuticals Inc · Deferred Revenue
MDGL Deferred Revenue
Latest reported$0.00period ending
MDGL Quarterly Deferred Revenue ($457.00K → $0.00)
Quarterly deferred revenue
High-resolution chart · PNG
MDGL deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -319,000 | |
| -315,000 | |
| -310,000 | |
| -306,000 | |
| -302,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -22,000 | |
| -33,000 | |
| -43,000 | |
| -43,000 | |
| -43,000 | |
| -42,000 | |
| -42,000 | |
| -42,000 | |
| -41,000 | |
| -41,000 | |
| -42,000 | |
| -4,000 | |
| -8,000 | |
| -11,000 | |
| -13,000 | |
| -13,000 | |
| 6,177,000 | |
| 5,973,000 | |
| -12,000 | |
| 3,303,000 | |
| 4,446,000 | |
| 4,572,000 | |
| 4,572,000 | |
| 4,572,000 | |
| 4,572,000 | |
| 4,573,000 | |
| 4,647,000 | |
| 4,892,000 | |
| 120,599,000 | |
| 13,782,000 | |
| 12,588,000 | |
| 7,017,000 | |
| 5,351,000 | |
| 5,351,000 | |
| 5,351,000 | |
| 8,046,000 | |
| 9,619,000 | |
| 457,000 | |
| 457,000 | |
| 457,000 | |
| 457,000 | |
| 457,000 |